Stenotrophomonas (Xanthomonas) maltophilia Urinary Tract InfectionA Disease That Is Usually Severe and Complicated
Shahe E. Vartivarian, MD;
Konstantinos A. Papadakis, MD;
Elias J. Anaissie, MD
Arch Intern Med. 1996;156(4):433-435.
Abstract
| |
Background
Stenotrophomonas (Xanthomonas) maltophilia has emerged as a causative agent of serious nosocomial infections. However, well-documented cases of urinary tract infection with this organism have rarely been reported.
Methods
Review of the medical records of patients admitted to a large cancer center with cultures yielding S maltophilia from urinary sources during a 15-month period.
Results
All urinary tract infections were serious: 13 were complicated and two were acute uncomplicated pyelonephritis. The urinary tracts of 13 other patients were colonized with S maltophilia. Most of the colonized and infected patients were hospitalized with genitourinary malignancy, underwent urinary catheterization, and were receiving antibiotics inactive against S maltophilia. Neutropenia and urinary structural abnormalities were significantly associated with infection. The clinical course of infection was usually severe: fever (100%), sepsis disorder (47%), neutrophilia (70% of patients without neutropenia), bacteremia (13%), and death (7%). Still, response to treatment was prompt.
Conclusions
Stenotrophomonas maltophilia urinary tract infection is usually associated with a severe clinical course. Risk factors for urinary colonization by this organism include hospitalization, urinary catheterization, and administration of inactive antibiotics. Risk factors for urinary tract infection include neutropenia and urinary structural abnormalities. In the presence of these risk factors, treatment for S maltophilia should be considered in patients with urinary colonization by the organism or in those with nosocomial urinary tract infection caused by an unknown pathogen and that is unresponsive to therapy with the antibiotics that are used to treat the common uropathogens.
(Arch Intern Med. 1996;156:433-435)
Author Affiliations
From the Department of Medical Specialties, The University of Texas M. D. Anderson Cancer Center, Houston.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis
Dekio et al.
J Med Microbiol 2007;56:1675-1683.
ABSTRACT
| FULL TEXT
Detection of potentially novel bacterial components of the human skin microbiota using culture-independent molecular profiling
Dekio et al.
J Med Microbiol 2005;54:1231-1238.
ABSTRACT
| FULL TEXT
Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia
Navarro-Martinez et al.
Antimicrob. Agents Chemother. 2005;49:2914-2920.
ABSTRACT
| FULL TEXT
Isolation and Characterization of Novel Giant Stenotrophomonas maltophilia Phage {phi}SMA5
Chang et al.
Appl. Environ. Microbiol. 2005;71:1387-1393.
ABSTRACT
| FULL TEXT
Novel Nosocomial Infections by Stenotrophomonas maltophilia: First Reported Case from Lucknow, North India
Mukhopadhyay et al.
J. Clin. Microbiol. 2003;41:3989-3990.
ABSTRACT
| FULL TEXT
Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa
Vidal et al.
QJM 2003;96:227-234.
ABSTRACT
| FULL TEXT
Identification and Detection of Stenotrophomonas maltophilia by rRNA-Directed PCR
Whitby et al.
J. Clin. Microbiol. 2000;38:4305-4309.
ABSTRACT
| FULL TEXT
Multiple Antibiotic Resistance in Stenotrophomonas maltophilia: Involvement of a Multidrug Efflux System
Zhang et al.
Antimicrob. Agents Chemother. 2000;44:287-293.
ABSTRACT
| FULL TEXT
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
Denton and Kerr
Clin. Microbiol. Rev. 1998;11:57-80.
ABSTRACT
| FULL TEXT
|
